دندانپزشک و کنترل استعمال دخانیات : تازه‏ها و رویکرد‏ها (مقاله مروری)

:

)

! "# $!

(

&' ( ) * + *

-.! / 0! 1) 2 **

* !"#$

** % & ' () !"#$

"# $! "3 4 :

29 / 2 / 89 9 :) 4 : 17 / 7 / 89

= ! "# $% & ' () # * ! +! ,' -. / 0 !

0 1+ . $ ! ! ! * 1 0+ . 3 0+!

$ 4 1 ' $ +! 5 (# 6 ! * 7 ! 0

. ! $' ' 89 ! :0 . - + 0 .

$ ; < . / 0 ! => ! $ ? @ A 1 B $-. / 0 ! * + C0

< D $ ) . / 0 ! E ! *!0( * + 0+!

:! F ' G H $ ' ,@ * 3 B

0 . $ I #! * ' B B 3 -. / 0 ! 0'

D J KF L M# 3 M E ! / " 0 :0#0 B M# ! $D * + *

$ ! . . 0#0 * +! -# : ! $( NG C* O 9 M# ! % C P ( ' -. / 0 ! E 0 :0.

$ !! Q .

> ? : +! . 0 C . / 0 ! C ' C E 0 C

.

/ 1389 34

/ 4 : 44 331 .

@A B C D E F! GH

B

420

» ! " «

$ % & ' % () * (+ %

, - . /0 1

2 3 ! ( 456

7 8 9 * : ; 2 0 " ' < + = 2 % > ? 68

5@ 5

» 50 « 1 + . ) 2 1 ( & *8 &E

The Dentist and Tobacco Use Control: Updates and Approaches

Atessa Pakfetrat*, Pegah MosannenMozaffary**#

* Associate Professor of Oral Medicine, Dental Research Center, Dental School, Mashhad University of Medical Sciences, Mashhad, Iran.

** Assistant Professor, Dept of Oral Medicine, Dental School, Mashhad University of Medical Sciences, Mashhad, Iran. Received: 19 May 2010; Accepted: 9 October 2010

Dentists and oral healthcare providers have a unique opportunity to motivate and help their patients to stop using different types of tobacco.

There are many evidences that they can have a principle rule in prevention and treatment of many tobacco related oral and systemic diseases and repeated nature of dental services and relatively prolonged chair time provide multiple chances for informing, advancing and assisting patients in tobacco Cessation. On the other hand, it seams that they lack enough education in this area, leading to not adhering to this professional practice. This review provides a comprehensive discussion about the new published approaches for dentists' intervention in tobacco cessation programs.

Key words: Tobacco cessation, intervention, smoking cessation, dentist, oral health care providers. #

# #

#Corresponding Author: Mosannenp@mums.ac.ir J Mash Dent Sch 2011; 34(4): 331-44.

******************************************************

# # # # +%,- ./" :

% & 1

"2 % 34 56#

: 15 * 8829501 * 0511

50 F ) *E & * + G 0 /* % ; &% 5; (+

* F < % G 0 ( 1 H I (+ .

$ J $ < $( = % " .

*E K ! L < $( .

. ) 2 (

(. F% % 20

E . ! . ( J /M* 2 3 % 8 3 5

N * + % 50 < + O 1

Camel I @* %8 + (+

:='1 8 P (+ &% % I > Q 0 + : % 0 "K ' %

4 % & R! " . %8 + ' "% + +S " T U0 . ) 3 (

:I W 6 50 /* @+ (+ &E 8%

( 8% ' /* &%K * 2 0X +

1980 $ % [

\ ] % . & % ! ( *8 8% 5@

> J " .

5 I 6 % .

) 4 ( 50 O8 *% H I (+

(T ; 6 6 " .

* 1 ) ! 1 .(

! 1 :

50 >X /M*

) 1 (

H I 5 J 0 " .

) (

H I

5 J 0 ? " .

> '

) 8% _ + 95 % % * ( ! " 50

' ) b5*

: % 9 + " . ' (

& + " 50 (spit)

; (

@* 7 H (+ &% % &E 8% : %

L < N R5\ $( = %

1

) c% $d J ( = % $

2

(; 4* > J @ % O 1 S e% % * 0 8% "%

8% 50 ; R E 2 0 @* ( % % &f 5 % *

:

1. Copenhagen 2. Skoal

2+ .

2 *E8 $d 0 * E " . g / J% " .

H < 50

210 % % . ) 1 ( 50 e% % & * $

* 4 % % F%8 & P hJ 2 + '

5 . .

@* ' 1

0 2

% 50 > ' ( +

. > '

P 7 + G * P (+ (U 10

* H 0 dj< 1

+ ' () E 100

U0 & *8 P dj< 30

H 0 (U

@* O 1 42

3 0 G M* > ' ;

* 5 . ) 1 ( k. ( @1 & + d J ' 7 0

* 3 % 0

2 0 % l @* % & . .

" .

. % 50

. + m* % R+ * >% m* K L <

H + ) f 5 n% 8% &E 8% 1 > % ()5 %

:1% .% J 50 1

. ) 1 ( $ 5 J 0 e% % + O o;

J 0 ? e% % $: % N hJ E ;% + K 5

% * & KI% + >X /M* 2 % & 6 8 ( p /J (+ F ) d.E 5 . (

1 J 7 % P q* rs! $

* % &E 8% 1 % R E F%K P *% 2 % ( 5 %KI%

* +% + 5t 5

.

" ' *% ; 50 e 8% b g

* K

0 1 ' 8% 1 * 9 * %

1 + > = * q* % I% > '

.

d f 3 ) " . I + 50 2*K* /*

) " I $ 0 ; (

F % )

F 1 ' +% ;% (

: % G 0 * .

) 5 ( O = % ' . (T ; ( ;% K! (+

* 50 8%

(; 4* $ 1 + " + 8% "%

" . d

" + * 4 % 50 n% &% & . " . ( 1

! 2 O 1 (goJ %

. ) 8 u 6 (

9 * w; + ( X ' G * P (+ 440

= %K.

8% _ + % 0 6

/ 8 " + :R! (+ = & * " .

* & ' + ( +% 1

. ) 5 ( 8% _ + ' 2

+% +

AIDS 0 * 9 * w; + > I / 1

. ) 5 ( G * P (+

" ' % I% 10

* . ' ? 8% 0 8 *

3 &% % 000

/ 50 * ' n% ( X = + *

> J @ % e 1 (+ (! 0

) d K 20 g (

_ < * 5 + 9 * 1 ' & 8% 1 ( X *

0 2019 (+ _ %KI% +% + Rt + 000

/ 200 =

+ . ) 9 (

! 2 :

50 /* l % ; 2 0 y 1

) 10 u 8 (

1 . " + d " .

•

" + ; " .

•

=50

•

& P ) ( & . (...

•

1 % 6 " +

•

: 0 E

2 . " + & . " .

•

& . & P

•

o< )3% o< )3

•

2*K* , 8 .

•

5 0 ) : 0 * %

•

(@ T snuff Dipper

•

" ' 8 o* .

•

% * & +8

3 . " + % " .

•

&% & 1 z + .

•

Abrasion

•

6 <

•

" + < " .

•

O 1 8 ) J8 : { f

•

H ! 8% _ + ) 0

•

& . :1% R+ @T

•

" + ) <E " < " . )

| (

8% O = % % % I : @ ! 7 % + '

" .

* > = * q*

1 + . 50 + 2 3 % } 0 5 % (+

N 0 G 0 ( *8 5@ $ 1 O E ( * J (+ .

:I ~% &E /* k. K 1 & /*

. ) 10 2 (

2 q0

: % _R! &% % ;% e 1 " .

* & *8 q* % * R! W %K6 7 % +

2005 : % & R! ;% [ 2 0X + "% % &% % $

8 / 2 "X + : @ ! g 15

@* &E .

) 9 ( 1 e

& ' % &% 16

g

: % . ) 11 u 13 9 (

&% * ' R! /* :

) 4 / 23 (% 8%

k J . ) 5 / 18 (%

: % +

. ) 5 ( 1990

/* *% + * • 0 ; &% % q* % * & 6 55

2 : % O Q0 '3% 2 % J% (. .

) 13 ( 5 2 ' *

2 + ( 1s6 ( K &% % ;% 25

0 29 O +

2 + O8 *% : % 10

0 19 : % O 1 W %K6 .

) 12 (

* 2 q0 > @3 h* J + ( 5 8

3 / 10 & % ! g

* ' F% P (+ &% % 5

. ) 11 (

(+ % % I " / % " . * < > J 8% O = %

>X /M* + ( U* &E (5 K. %

@ % N 0 :R! (+ * " . % 2 0 ) 2 K' ! * % > J * (! 0 + + $ 6

1 + . ) 15 14 (

/* % % I 2 5€ . GJ 8 ( " % I% '

* 6 8 UI : % + 55

. ) 16 ( 5* W %K6 d

" " + > U UM0 * 5+ G 0 O 1 2006 ' & ( %8 (5 K. % &% %

100

&E ] % 63000

&E ( %8 2 ' * : %

4680 : %

. ) 16 (

1 A

C D (

@ % 8% 1 >om@ * O 6 (+ •% 4 * * (! 0 &E H % % ;% > J (+ 8 $ 1

+ ( • * 2 % )1K< & 5 ( : *

* 7 %

6 .

; $ oJ% $ X

u "% + % % I " +

kR* _U

p /J (+ * 1% R+ & 5

8% ( % ! > J @ % 5 & )1K\ % * ( ! &E O 1% 8 % * (+ &% 0

: ) 17 (

1 u & . :*o :1% R+ & 5 & )1K\ %

> J @ % ! l % ; 8% * . 6E

% ,) I % ( .

2 u (+ & )1K\ % & " % % 0 * > g

* : K % & % ! " %s6 n 0 :g I 2 % + 5+ $ 55

* N 0 :R! " 2 3% I . " + % % > J @ % _. .

3 u (+ : $ )1K\ % & * 2 & )1K\ %

* ( % J% " + :g I & )1K< "% + 5 % 0

J &E 8% . 6E " U0 % > J @ % 5 :3

5 O = % .

4 u k J & )1K\ % :R! % % + " .

F 5.% P & 1 J & . :1% R+ :*o " .

* > o* $ %8 3 0 8% @+ " % + * 5

5 % 0

5. % . " % + &% % > J l % ; .

+ 5+

& )1K\ % $ )1K< 5 2 %

* &% & . &% :1% R+ O8 * (U 5 % 0

O 8 + ‚ : ]0 w; + ( I 6 % > J @ %

6 0X + .

5 u %

)1K\ + & & % &

; * l % * + & . > J

+ " n * > g (+ 5 % 0

5 > J @ % N 0 (+ ƒ 0 %

. + ( % t

+ l @* •o* & . $ J% " m;% oJ

. „ :; (+ &E ' l % ; O +

* 6 . ) 19 u 17 (

" + $ " . 8% " + O8 *% 2 % + 5+

0 > J @ % 5 d1K\ % _U

W8 *E ( I 6 > g (5 *8 2 % & E "% + @ " .

(I : 3 @I (h : %

( I 6 % R E "%

: % . ) 20 17 (

: * ( : % O …q * > @3 h*

" .

+ †3 + > = * 80

@I > g (+ & )1K\ % g

: 3 @I > J @ % N 0 J &% + (+ d

% . ) 21 20 (

(@3 h*

( : % O …q * &% % J% "%

N 0 "% + % J &% + % % & )1K\ % 8% " +

* ƒ 0 > J @ %

5 . ) 22 ( > @3 h* I P 8%

@ % 5 O * (+ % % & % ! ( :+ n

* & : ? > J 5.

. ) 23 ( 8 5. ( = * ( 3%

&% 5; (+ > J @ % N 0 (5 *8 W8 *E &% %

: * ; )1K\ % 18 *E H 3 ) 8% FK!

* b (+ : 3 @I 2 5t ( " % I%

$ 5 J .

7 % /q1 ( o; :R! (+ + % 2 %

(I „ 8% q+ &% 5; (+ ( " I : 3 • *

"%

* H 4 % J 5.

.

& " .% " ) ; :R! K @ % * *%

* ( : % ( 1% ! . 2 %

8 % * (+ &% 0

O 1% :

) 25 24 17 (

1 u ;% "% + I OK ' % & )1K\ % () E %

2 u ( 5 + y % ? ( % 6 E O % K 0 + "%

% ! : UI * &%K * .

3 u % (5 *8 2 % H8X > R* & )1K\ %

% % H8X . 6E 0 ; (+ O ) .

4 u : 3 • * &% 5 ; (+ % _U 2 % & )1K\ %

(I % ( I s\ J "% .

5 u : &% + ( 3 % : K H '5. & )1K\ %

% " M* .

&% ! + " 0 (/ U 2 % ( 3%

& * H 4 % H '5. ( % t : % )1K\ % " .

* d1K\ % : Mg + + % 0

!

6 u N 0 + 0 $& )1K\ % 8% " + b (+

d1K< ˆ 0 % & W q* w; + > J @ %

* + 6 .

& ' % I% 8% " + k;8 (+ () E + O o; *K* " + d : % " I ) * d O 2

8 hJ I d &% 5; (+ % &E % I% " + % . ) 17 ( * b (+ y % * 2 % H 0 k? ; _U k. 8 +

O + % + > J @ % N 0 & )1K\ %

( M* + , d &% 5; (+ +

(* + "K " . 1 ( I 6 b ' N 0 ‰&o .

) 26 (

(U+ *% 2 % . 8% " + ( ( =6 ( 3%

% (5 .

% & )1K\ % 2 4 % % •o]*

1987 k U * ? k U * _U O + ( + d

% ' 8% O = % g :*o '

2 *% Ho;% e 5 * * ; .

$k. &E 8% ,< 5t

(h % > J @ % 5 "% + :3 J

(I : 3 • * % % & )1K\ % "%

. T

(h 2 % & 0 ) < K! 2 % )1K\ % k

: % . ) 27 (

C D ( I@A "? !

0 N 0 :R! ( J% * H 2 3 %

' 5

g . 0 > * 8% @+ ( : % @I 5* (+ O 1% 1 .% J .

! % * : + 3

1 + H I (+ %

k . % H ; l @* k F ( R0 <

. ) 28 (

! 3 ( 1 + H I ( R0 :R! " R5 < "%

* ( : % <

H ; l @* % &E &% 0 %

% . * b (+ N 0 :*o 2 //q * ] % b

; $ 1 + 5 I : ) * + 50 @ %

8% 50 ; *% 2 % :

& * 5 E I & 1 ( q 6 % $ n * " .

I W8 *E I ƒ 0 $ I & *8 $& * d 5)0 (5 *8 )1K< O * " .

8 *

50 @ % N 0 .

) 29 (

; > *% % H 4 % :3 J (+ e 1 " @+ H : % > J @ % N 0 "% + I (+ d "% + .

> g b5* 2 % (+ R! Šh > *% % " d * 8 % * * 1 ( : % ( I 6 1 +

:

1 u >% hJ * < O + H * . 6E " U0 %

@ % > J

2 u 50 e 5 * >X /M* : _ %KI%

3 u ' W I J y5* )

8 5. &% % ( 3% (

: % O % !% (

4 u * ; 2 *% ' 8% O = % y5*

5 u

5= 0 O * ˆ hJ 8% O = %

6 u 2 0 ) 2 K' ! + & * )

NRT ( Nicotine

Replacement Therapy .

7 u

O * H 4 %

! 3 :

50 ' e% % ' N 0 " %K*

) 15 1 (

8% @+ 20 8% (U

' 2 JE

1 ( * + * :3 (+ & J I 6

.

2 ( * " ; ‹ & + T 1

.

3 ( * X + " ; :3 0 < : " * .

8% @+ 8 :; 1

( * + " ; :3 (+ & J 2+ 5* Πh 6

.

2 ( J &{ % Šh * X + @ P &%K * 0 &

.

8% @+ 24 :; 1

( * _. ( , 1 +

.

8% @+ 48 :; 1

( ( < * > ; 2 0 ) (+ /; " . 55

.

2 ( * R+ F t + : + +

.

3 ( * 2 + 8% & . " 50 " + .

8% @+ 72 :; 1

( + 0 O ,=50 O 1 1 " " . * 0

1 .

2 ( * _ %KI% ( : + +

.

8% @+ 2 0 ( =. 3 O * 1

( * (b o* + R+ & J & ! +

.

2 ( % " O < :R! + 6 *E & + .

3 ( 0 ( 2 ) I 30

% * _ %KI% +

.

8% @+ 1 0 19 O * 1

( * R+ ' . ,=50 . 0 ' J $& U % $(I 1

.

2 ( N{* ( " . * 7 * "% % O 1 "8 8 + =50 H 0 <%

N < &E •4 ( 1 "8

: % " : =; % _. ( .

3 ( * _ %KI% & + "f % +

.

8% @+ 1 1

( R50 " + 8% 1 9 * 50

% : % " ' ? % I% 8% + .

8% @+ 5 1

( " + 8% 1 * 9 * : % " ' ? % I% Ž8% % (+

.

2 ( R50 & P 8% 1 9 * 50

% : % + " ' ? % I% 8% .

8% @+ 10 1

( * 2 K' ! @ P + •o ( & . k J + _ < " . 1

.

2 ( : % @ P % I% Ž8% % (+ ( & P 8% 1 * 9 * .

3 ( & P 8 + &%K * " .

) . 7% ) < ( $( ]* $" * $O 45 $& (

" ; % I% Ž8% % (+

* 1 .

) *E :*o * ; , Public Health Sevice

(PHS) 2000

g% &% 5; (+ % F 5.% ˆ hJ $ & *

» 50 (+ ' +% «

1 h* )1K\ % " .

: % O % (F% % )

31 30 ( % * 2 % * 1 ( *

1 + :

» 50 (+ ' +% «

: % 2*K* " + ; .

[ &% + 8% % g F% N 0

* . . &% + ] %

* /* % 50 .

55

O * (+ 40 % 4* ;% :• * N 0 8% " . 5

.

X + % * H 0 k? ; »

50 (+ ' +% «

P

0 Ž : % & * + )1K\ % h* . .

% I% + & )1K\ % »

50 O 55 O = % «

1 %

I WK ' % 5 ƒ 0 N 0 (+ F 51

5 (F% % R E (+ % H8X % & * O *

.

( g 0 F% !% _U &E d1K\ % ( g% " .

5; :M0 • ohg% % g%

@3% &%

"Five A"

* O * * 1 ( $ 1 5

: % 8 * .

) 32 (

•

% > J @ % (+ y!% J + 8%

5 ) ASK .(

•

> J @ % N 0 "% + % + •

5 :M / F 5.% )

Advise

( .

•

@ % N 0 % + : ? &%K * • 1% F + 8 % > J

) Assess .(

•

& N 0 "% + % J 0 ( % +

* 5 d 5. (Assist)

.

•

5 "% + • : &% + 2 % 0 * " .

. H 4 % % H8X '5. . )

Arrange .(

8% "{0% % 2 %

3 •% ] % % H8X : (U

J % !% + )1K\ % : K @* & *8

.%

+ . ) 20 (

J K : L )

(ASK) ) 33 (

> ; + H 0 8% ( 5

@ % Ž + J &%

1. Tobacco user

5 _ < > J .

H I 1 (Uh5* 6%

" .

50 ) & $7 5 * (...

O + • : % y 1

\+ R E .

8% /* O M & *8 > * $ % )0 $e

+ ( : % F * 1 O <

. ( * %

*

+ ( : % 2 % % + 50 N 0 :R! 5 % 0

% &E : .% k U * ? > /+ &E O + & < 5 K1 6 .

) 34 ( O ' _U & * 2 % O 5. hJ% " .

+ 8% %

. ) 35 (

J J K : " MC

(Advise)

) 32 (

H 0 (+ • +

»% 50 & 6 55 O = «

% E N 0

* ( g 0 $ ( g 0

: + :

1 ( ŠT% : » * )I 2* & N 0 1 "% + k5

* d % 1 2* : % !% 50 '

k5 «

& + % 50 /* & % (*% % l % ; +

1 + + "% + +

.

2 ( " : » ( k '+ + 1 d1K< &% 5; (+ N 0

' /

1 ( : % "K t 2 R* T 50

% 1 d 5 2 % . H 4 % J *o "% + + * " (5 *8 2 % 5

.«

3 (

I G % 1 + 5 *

:

(+ % 50 0 5 @

+ @I ) * " + )

" + $ 6 < •o]*

=50 / * + ( R+ 8% <

( (+ . G+

& 8 O 1% " 6 *E WK ' %

+ ( .

* M0 I O % J 5 K1 6 % 1

. ) 33 (

JC J K : GN

Assess)

) 32 1 (

5* * % % : % N 0 (+ * I 6%

5 : % . .

( $( g 0 8% @+

(+ 0 ( 5 . "%

N 0 % . )0 < % I% 2 % "Five R"

.% J )+

•

Relevance )

" I " . (5 *8 " . OK ' % :(

2 I

N 0 O 55 ( ! 0 $p J I &E ( /q1 F * $,5! $2 $O % J " m;% $" + 5 * ‘ 5 . O ? > + 40 .

•

Risk ) d :( ' H % 0 >% hJ & 1 + /

50

% >% hJ 50 e & l ; ()5 % + 0

yI 5

. ! 2 @ % & 6 6 >% hJ

' /

* ( O 1 O 1 + 50

+ "% + % R E &% 0

1 + .

•

Rewards )

yI 5* :( ' N 0 8% g yI 5* /

* 50

55 ƒ 0 N 0 (+ % + 5 % 0 :

& 1 R+

$ F ! (I g $ F + , R+ $ *o Ž ;% $%s? k@P

(+ % P% & + & 1 + W J K 0 $r J 7 %

7 8 " < 2 J% % J 0 )

! 3 .(

•

Roadblocks )

& R5< y % * :(

@ % * + d1K\ %

' @ % N 0 :R! + 2.S (

/ 50

O% F 51 % % ! R E :R! ! * " .

5 + + (+ % .

8% 7 0 & € . @ % *

2 1% $ t $: )1 8% 7 0 $N 0 8% 1 >o) *

>s3 & % : 8% 6 I% $&% ' :

'• . ) 32 (

•

Repetition )

% )0 :( (+ & % OK ' % H % * ƒ 0

6 > g ( ! . + + .

+ N 0 (5 *8 ƒI * % I% H 0 ( 1 + ( 1%

: UI * g % O (+ 40 % : )1 . + . + Wo0 O M * >X % N 0 :R! " % = % " . 2

0 4 %

(+ &%K * 2 % & )1K\ % ( J% * + () E : % 12

0

15 % : % R! 0 + &%K * ( O .

) 32 7 (

+ * 8% " 3 h

+ : UI * &%K * > @ (

O *E :

8% + " * & )1K\ % G 0

…/q0 : % O + G 0 * " . .

) 8 7 ( 0 g 2 %

* )1K\ % h* % , 2 % ( : %

+ &% 0

5* : % (F% % " 0

. ) 32 17 (

J @= J K :

(Assist

) 32 (

OK ' % "% % + (+ 5 d

.

1 ( „ …q * } 0 d 2

"% + O 5 E ( =.

5 I @* N 0 .

2 (

% &% ) . & $O % J .% q+ + 8%

.% q+ " R E 8% ( 1%s6 J k /0 & ! .

3 ( O{ (+ N 0 kFo; b 5* + '+ + (+

1 + % ( =. 5t .

4 (

8% % 50 >X /M* 5 ( g 0

+

5 y ! J .

( 5 *% $N 0 (* + e 1 8%

* 4 E % & *8 2 + ) ' $ % s6

.

5 (

+ > 1 @* ]* 8 G % 1 8%

" '

* 8 % : )1 % ( ’R " .

$ 5

5 " .

6 (

/ J + O 5 %K ' % + >o !

5 ) . 0% r " •o]* (5 E $ €q $•

(...

7 ( . % b * % F % & * .

OP ) J K :

G1

(Arrange

) 32 (

&% 5; (+ % J g% _U ( O &E : X 8 ?E d1K\ % .

@ % 5 H8X > *% % & * e 1 "% +

d 5 h* ( 0 % + > J

\ % O % &% + (+ > J @ % O8 !% $ )1K

d 5 " ' ! ]* 0o R 0

( . H 4 % % > *% % " ) + d1K\ % 8% 50 ; :

1 ( ( R0 * (* + (5 *8 2 % 0 1 d + (+

5 .

2 ( K 40 % % "% + .

3 (

$K % * + % +

(* + &% *

! * " .

8 51E (5 *8 2 % " .

4 (

: r + % +

(t (5 *8 2 % @* " .

51E 3% 2 + J% > g (+

. 2 5€ .

* : = < 1 + $ < &% 0 ( R0 •o ( F .

+ J% % % ! h* O 1 O % % .

+ / q* O * ( > n% > @3 h*

&% + ) . 6 " I (

Tobacco use counseling

(TUC) . (+ $: % O KI% % : UI * g &% + +

O *

* . & 51 + " m > /+ % 0

2 % + &E " 5 * 1 + 5= 0 GJ d + (P + * : % % % 7 % * (

:1% + )=0 8 P &% 0

4 % Q0 $& ' 8% +

. ) 32 ( 2 % + O o;

( W » J 51 Q0 «

1 * * & *8 Ut . 1

.% J + : UI * , 1 1 + + *o 7 0 2 % + . ' W »

* I «

2 8% + % + ( : %

& )* m .

: @ * @ % , o1 ( F .

* O KI% > J y5* $ 1

. W 2 % * % .

&% 0

2 K' ! + O% . . % 5 0 ) " .

. ) 36 (

( % ! % 2 5t FDA (US Food and

Drug Administration) n * " . % &% 5; (+ % R E

1. Cognitive change 2. Behavioral therapy

+ * ' N 0 hJ

: % O I @

. % r q %

O * ( P & . % > =0 I (+ ( +

.

(* + I G % 1 (+ ' + K F % ? "K

> R* :1% .% J % " . .

T 2 0 3 O *

' N 0 :R! * %

/

* ( g 0 50

1 .

:g I + ( : % 0 * *8 O8 + 2 % *

% + +

+ 5 N 0 kFo; R„ & + hJ < G % 1 + ) % 6 O * .( W 5t . * I + 5 * " .

* % 8% H% 0 O = % 3 5 . =* K g

* * I (+ % > * X P N 0 , 1 % 0

. _ %KI% R! 0 + .

* O 0 & * :R! >

* ( g 0 K N 0 + . (+ + 1

» O 55 /*

50 « % R5 < % E .

) 32 17 (

N 0 O (+ ˆ + * O 1 S " . % ] % (t 6% * 3 5 . ' N 0 & *8 % R+ * k f &% 0

:I 6 )+ K 50 e% %

. ) 1 (

C D ( I@A G !

P (+ ( * 1 ' N 0 * %

: % :

1 ( & * 2 0 ) 2 K' ! " . NRT

) Nicotine Replacement Treatment (

2 ( & * 5 0 ) ? 2 K' ! " . NNRT

) None-Nicotine Replacement Treatment (

NRT Nicotine Replacement Treatment

W 8% b5*

) NRT ( & * 2 K' ! + " .

% * I ( : % 5 0 ) y 5* 8% O = % 5 0 )

* 2+ 5* $&f 5

‚ + ( 1 +

& + " 50 @ % ' 2 K' !

* 6 . ) 17 ( N 0 &% UI kFo; () E "% + . „ > J

2 0 ) J Šh + 15

0 18 6 3 * H

1 + .

(+ % 2 0 ) J Šh :; (+ ' d

35

0 40 * 3 H 6

7 % (+ 40 w; +

5?% ) Hit Rush ( 1 * & ' H '5. ( 6

l ; 25 0 30 * + ( < (+ (U 6

. _U

NRT E & + % J Šh ( : % 2 % y %

()

kFo; ( " M (+ “= $ 1 4 % 5?% 7 %

' . „ N 0 .

k U* (+ ‚ 0 (+ + ,\

* > ; 2 0 ) J Šh

2 % ( *8 0 5

+ =g (+ k .

) 17 (

8% O = % 8% .

NRT kFo; _. s

* N 0 * d N 0 P % I (+ 1 + + 0

" I ”%K!% u

+ 5 J ;% % ; !% .

kFo; O 1 . „ 1 " g 2 { E kFo; 6%

:1% 5.% J /* y5* . % 2 % 1 0 + +

.

/* y5* % * K! % < " g 2 { E NRT

r M* 1

. ) 37 ( $" F 0 \ . t &% +

:+ kJ8 2 3 % (+ ( +% @I d \< " .

NRT

1 /* ˆ % + +

. ) 37 (

NRT : : % H 4 % + W 5t 8% :

-< $ < " .

5 + " \ % 5 % $ )* p $,*% E

.

>X /M* ( . NRT

%s? & *8 0 *

) *E " % (FDA)

F % & * % GJ O +

:R! ƒI *

* r M* > J @ % N 0

1 .

r q % NRT $( %8 I /* ' % @0 7 % +

: % > = * + Š ! 0 &E M* ! >% n%

. ) 37 (

1 .

Hit and rush

: n% ( '• 5?% & $ * 6 , ;

/* N M* O * . '

CNS

* 4 % 1 . H % 0 X 8% )

* , 2 % (+ & :R! @* I " 4 ! ;% 1 +

.

+ ( 3 % U* $ 1 + 0 ( +% > J (+ + (t .

1 ( I 6 b + .

-< ]* 0 W 8% K • . 6

0 W d

)* p $,*% E ]* n% O

* 5 + " \ % H ) R E & * 8% $ O = % &% 0

) -<

< (

> g (+ )* p ,*% E $

OTC O +

d1K< K 40 (+ 8 5 % 5 + " \ % e% %

% . ) 38 ( .% . NRT

O * +

: UI * , 1 //q0 " .

* _ %KI% + % .

. ) 1 (

Q) G C )

Habitrol®, Nicotrol®,

Nicoderm®

:(

-< 2 % (+ N 0 kFo; _. s b5* (+ .

* . + 1 ' $-< 8% O = % 8% 8 /

50

1 yh )

( g 0 b :M0 2 % d1K\ % kb5* " .

X + : UI * g 0 1 H 4 % + .

@* (+ •X

* M0 + J $W J % 8 5t GUI 1

: % 2) * < -< M* W8 7 % "K*

1 7 %

. + • . 6 ” $ +% J >om; $( T .

: % 2) * 5 . 8 (+ ( +% ' . ( (I & + 1 4 % .

/* 8 P 1

: % O *E .

) 31 (

*! + G C

Nicorete®

:

d + 2 0 ) 4 0 & 2 K' ! :R! ,*% E

* )+ ! K t

. 5 * $ 1 % 6 l % ;

” $() ) &E y 1 l % ; 8% }= e R0 $( T .

: % . $&% : & 1 ƒ3 $( 6 2 I 6 8 6 $dI

•%K+ & 1 8 W8 7 % + k@P $ . kJ8

. &E l % ; 8% 5

.

/* 8 P

1 O *E

: % . ) 39 1 (

G C G ! R S

(Comit®) :

> rE ( 1 H I 2 % " % R50 )* " .

y

F 0 * nX%

FDA * 1 + . (+ 8 % 2 %

+ + " T U0 8 7 % + ( 1% d1K< K 40

: % /*

. p 2 % * .

J Šh 5 % 0 2 0 )

$ ' l % ; & + O + X + :; (+ % 2 K' ! % E % * .

N 0 :R! • I g % 2 %

(+ 8 5. 50 e% % N 0 O 1 ( g 0 '

: % O F 0 .

5 $O = % + 2 5t 3 (+

* 4 % N 0 kFo; + % " R+ .

) 39 ( 8 P O = %

1 : % O *E .

G N J ' "N / C

(Nicotrol NS®)

GS T

(Nicotrol®)

:

&% 6 . % d1K< K 40 (+ 8 H I 2 % 5 . : .

"% + % " n% 5 % H I

" '

: 5* ’R " .

. P 6% % 2 % 4

51 5* ( =.

1 yh + .

( O % & > U UM0 NRT

*

N 0 % % 0

% ' 5

/ 1 0 2 + & *K . 6% . _ %KI% +% +

:1% .% J FX + F% 1 + ' N 0 O *

. ) 40 (

" + K 3 E * (@3 h* d 6

F% "% + (@3 h*

K 40 NRT

0 O * ( )1K\ % h*

+ H%

NRT H% 0 O 6 ‚ : % O ( U* &E & + + %

O * +

3 : % O % & " 0X + : UI * g .

) 41 (

9

G C U G3 / 1 A

NNRT

(None-Nicotine Replacement Treatment)

:

& * % GJ TNR

N O 1 0 $ FDA

+

Bupropion SR )

" 40 H

Zyban®

( d ( : %

: % g / J% ? 6 I% T

. * b (+ 2 %

O% " + % O% & + + d f 5 * < " .

" .

n 0 2 0 ) N 0 ;% 6 d f E

* %s6 . ) 1 ( >X /M* O% . F R50 (+ % 2 % NRT

+

: % O + n * O * > ! & +

. d 3 ! ( I

*% : % ' N 0 8% 1 t 8% " 6 ! % 2 % % K 40 H ; ‚5 0 (+ @ * o * &% + .

"% % ( 1% "KQ* ( ) % ! $ * 0 ( & J >Xo J% p /J (+ % o J% . )

5 *

3 + ( % 2 % K 5 . & 5 < /* %

55 .

_. $& . ) J $ 6 3E r% J

: % % 2 % l % ; 2 0 y 1 R 1% .

% 2 % 2

* ( : % 2 % e 1 % &E N 0 8% ( =. 8% &% 0

( 3 NRT

5 N 0 % ' + • +

2 0 ) 8% 1 : 0 e 1 % % ,\

% 4 .

) 40 (

*% O 1 I @* H GJ &% 5; (+ ( ' " . % 0 FDA

ƒI * > J @ % N 0 % %

8% 50 ; 1 ( J 51 :

2 \ 0 2 .

) 39 (

•% J% FDA &% 5; :M0 " ' " % vareniclin

E

2 0 ) O 6 : 6E d (

α4-β2 ) t =3E R

+ ( *

% 2 * < ( : % O I @* % 1 +

* * % 2 0 ) O 6 d M0

>% n 0 8% 5

> J @ % 8% 1 : U0 0 J8 +

* " 6 ! .

) 39 (

1 :

50 N 0 O = % * " . % /* 8 P

) 15 1 (

-< " .

5 0 ) > * (+ < t d "8

6 5 O = % ( =. ) .

"% % 22 u 21 2 0 ) H 6 * (

k3 M* % -< Š g "% +%

0 % €+ 1 + * & + d J ( : < 8% "K 0 1

O = % -< & t "% + •% 4* % M* &E ( =.

5) . * " @+ " .8 8 + -< 8% &% 0

O = % .

+ 0 + : I F R50 (+ . 6

1 O = % R1 .

8% % I% 18

( ) 68 0 (+ ( " % I% E t &% + $( * O 1 & 8 $

55 O = % -< 8% % O .

-< 2 % kJ8 $ * * •I t % I% . " R + $& J I $:+ $d \<

1 /* d1K< $O * + + ( " + $ 1 < .

,*% E " .

5 0 ) 1 8% ' ,*% E 8% O = % 8%

H 6 " % " . )

@ 3% ” * $O +E $(+ 1 $O R " t ]*

1 ( O = % .

,*% E + ,*% E 2 % & ! W % • I 3 @* " .

. (+ % +% + % 5 0 ) ,*% E

1 4 % & . * * 7 % 50 ŽK* ( 0 ! ' .E .

% ,*% E O * % & ! & *8 2 %

* (' & . F ! k %

) . 4+ W u % (' ,\ (

(chew chew, park) 8% @+ 50 ŽK*

1 2 + 8% (U

* & ! (+ e 1 O + :I * (' & . 0 = * " ! 0 0 2 . (+ k 5

k % . 0 2 % 30

H 4 % (U

* ( J% % ,*% E ,\ O 1 1

. 20 0 30 ,*% E mg 2 * ( g 0 8 /* & *8 > * 1

3 0 6 O *

* 1 + . 1 + 4 0 &E yh : % R+ .

-< (+ * /* y5* % * "% + W 2 % ()5 % O o@+ : % 5 0 ) " .

: 5* 5 . ) * t )I . '4 6 /=* ( " % I% .

)* p

* ' r% J 8% @+ :; k „ + 6% p

mg 4 p > g 2 % ? mg

2 * O = % 1

.

1 0 ) + ' .E (+ ( 1% (' & . p d )

• U0 5 / 0 :; ( & 1 2 T K y+ d 8%

O J "K t p .

* 1 % 6 l % ; 4 % p & ! R6 & @ + 1

. + % 2 % 5

1 K &% % I rE .

* & *8 1 /* > * + + '

. /* ] % 20

+ ) ) > g (+ p

: % 8 d 5* *8 ( g I .

P 6 ] % :; 5

* p )* &% 0 .

p

ZYBAN

p d "8 mg

150 p ,\ % 8 ( O 'M g )

( g I % + R„8% @+ " ' Š g ) 8

:; ( . 1 /* p 8% _ + K6 .

K "P

* e 4* 1% R+ & 5 ( :=6 &% 0

u

> J @ % ( " % I% F 51 (+ „ * *

* % @ % N 0 (+ ƒ 0 % R E + 51 +

55 d & E (+ O% 2 % O > J .

) 20 (

…q * > @3 h* (

70 " ' g 0 .

5 N 0 % J ' % .

) 42 ( " % I% % @0 5t .

k + ƒI * % I% + 7 1 N 0 (+ ƒI * ( *

1 + . ) 42 ( (+ K & )1K\ % $ 1 O 1% ( X (+

: 3 • * :R! (+ ( 5 . " % I% 8% ) &% 5; (I J "% > R* + &% + :*o 2 * 0

"% + J &% + (+ d "% + % H8X WK ' % . 6E

5 @ % N 0

) 20 ( : % H8X % 2 %

H 3 ) O ; >% Q0 )1K\ % 18 *E " . "%

:J 8 0 s< > g 6 k.% I *% 2 % " .

.

h* " . \ %

* 8 ?E & . O = > J @ % + 1

I @* $ o % k I _ * 1 > *% % (; 4* & . > J l % ; % * 1 + $: = <

* (*% % + 5 O *

2 % (; 4* ( +

+ > *% % NRT

0 % : UI * , 1 20

_ %KI% g

* . . ) 32 ( O % % & )1K\ % T 18 *E " .

@ % 5 (h (= „ H 4 % "% + 5*

% "K (* + (+ 8 % O ) " \ % > J % ! :R! 2 %

. ƒ UM0 d ( p /J (+

* & . & P (+ y!% % I% . 6E " + R

% I% 8% " + ( 1 …q * )

8% _ + 80 (% % '

& . & P * ; &% 5; (+ 5 51

) 43 (

(5 *8 2 % H * & O 6E (+ : + & )1K\ % W8 *E (€ 5t 5 Wo0

:I 5* " .

* 5 > J @ % N 0 " n * _U 5 % 0

1 + ( 1% 5 .

VN !

1. Mohammad AR. Tobacco Cessation: Clinician's Guide. 1st ed. Hamilton: B.C. Decker Inc; 2006. P. 1-9, 35-40,

46-8.

2. Doll R. Tobacco: A medical history. J Urban Health 1999; 76(3): 289-313.

3. Slade J. The tobacco epidemic: Lessons from history. J Psychoactive Drugs 1989; 21(3): 281-91.

4. Mehrabi S, Delavari A, Moradi GH, Esmaeelnasab N, Poolady A, Alikhani S, et al. Cigarette consumption in

15-64 year old Iranian population, Year 1384. Iranain Journal of Professional Epidemiology 2007; 3(1,2): 1-9. (Persian)

5. Henningfield JE, Benowitz NL, Slade J, Houston TP, Davis RM, Deitchman SD. Reducing the addictiveness

of cigarettes. Tob Control 1998; 7(3): 281-93.

6. Mosannen-Mozaffari P. Evaluation of the diagnostic value of a modified liquid- based cytology using oralCDx

brush in early detection of oral potentially malignant lesions and oral cancer. [Doctorate Thesis]. Iran. Dental School of Mashhad University of Medical Sciences; 2007. (Persian)

7. Hanioka T, Ojiima M, Tanaka H, Naito M, Hamajima N, Matsuse R. Intensive smoking-cessation intervention

in the dental setting. J Dent Res 2010; 89(1); 66-70.

8. Squier C. Introduction: Tobacco, human disease and the role of the dental profession. J Dent Educ 2001; 65(4):

303-5.

9. Moghimbeigi A, Eshraghian MR, Mohammad K, Nourijelyani K, Husseini M. Determinants number of

cigarette smoked with Iranian adolescents: A multilevel zero inflated poisson regression model. Iranian J Publ Health 2009; 38(4): 91-6. (Persian)

10. The cigarette “transit” road to the Islamic Republic of Iran and Iraq: Illicit tobacco trade in the Middle East. 2nd

ed. Cario: World Health Organization; 2003. P. 53.

11. Kazemi A, Kazemi A, Nekuei NS, Zandiyeh Z. Smoking pattern in high school students in Isfahan. Iranian Journal of Nursing and Midwifery Research 2008; 13(1): 36-9.

12. William Samii A. Drug abuse: Iran's "thorniest problem". Brown Journal of World Affairs 2003; q(2): 283. 13. Delavarian Z, Pakfetrat A, Mahmoodi M. Five years evaluation of oromaxillofacial malignancies in patients

reffered to Mashhad dental school. J Mash Dent Sch 2009; 33(2): 129-38.

14. Paul CL, Ross S, Bryant J, Hill W, Bonevski B, Keevy N. The social context of smoking: A qualitative study comparing smokers of high versus low socioeconomic position. BMC Public Health 2010; 10: 211.

16. Tafti SF, Jamaati HR, Heydarnejad H, Heydari GR, Milani HS, Amini S, et al. Daily expenditure of cigarette smoking in Tehran. Tanaffos 2006; 5(4): 65-70. (Persian)

17. Warnakulasuriya S. Effectiveness of tobacco counseling in the dental office. J Dent Educ 2002; 66(9): 1079-87.

18. Ramseier CA, Warnakulasuriya S, Needleman IG, Gallagher JE, Lahtinen A, Ainoma A. Consensus Report: 2nd European Workshop on Tobacco Use Prevention and Cessation for Oral Health Professionals.Int Dent J 2010; 60(1): 3-6.

19. Burt BA, Eklund SA. Dentistry, Dental Practice and the Community. 6th ed. Philadelphia: W.B.Saunders Co;

2008. P. 294.

20. Davis JM, Ramseier CA, Mattheos N, Schoonheim-Klein M, Compton S, Al-Hazmi N, et al. Education of tobacco use prevention and cessation for dental professionals-a paradigm shift. Int Dent J 2010; 60(1): 60-72. 21. Mecklenburg R. Tobacco effects in the mouth: NIH Publication; 2004. P. 5-15.

22. Khoshnevisan MH. Iranian dentists attitude toward smoking cessation programs. 2010; [1 screen] Available at: URL: http://www.IDAweb.ir. Accessed June 01, 2010.

23. Ziaaddini H, Meymandi MS, Zarezadeh A. The prevalence and motivation of cigarette smoking among Kerman high school students. Iran J Psychiatry 2007; 2: 41-5.

24. Campbell HS, Simpson EH, Petty TL, Jennett PA. Addressing oral disease-the case for tobacco cessation services. J Can Dent Assoc 2001; 67(3): 141-4.

25. Watt RG, McGlone P, Dykes J, Smith M. Barriers limiting dentists' active involvement in smoking cessation. Oral Health Prev Dent 2004; 2(2): 95-102.

26. Helgason AR, Lund KE, Adolfsson J, Axelsson S. Tobacco prevention in Swedish dental care. Community Dent Oral Epidemiol 2003; 31(5): 378-85.

27. Brothwell DJ, Gelskey SC. Tobacco use cessation services provided by dentists and dental hygienists in Manitoba: part 1. Influence of practitioner demographics and psychosocial factors. J Can Dent Assoc 2008; 74(10): 905.

28. Sandhu HS. A practical guide to tobacco cessation in dental offices. J Can Dent Assoc 2001; 67(3): 153-7. 29. Koerber A, Crawford J, O'Connell K. The effects of teaching dental students brief motivational interviewing

for smoking-cessation counseling: A pilot study. J Dent Educ 2003; 67(4): 439-47. 30. Tomar SL. Dentistry's role in tobacco control. J Am Dent Assoc 2001; 132: 30-5.

31. Needleman IG, Binnie VI, Ainamo A, Carr AB, Fundak A, Koeber A, et al. Improving the effectiveness of tobacco use cessation (TUC). Int Dent J 2010; 60(1): 50-9.

32. Tomar SL. Tobacco concerns. J Am Dent Assoc 2007; 138(2): 152.

33. Stafne EE, Bakdash B. Tobacco cessation intervention: How to communicate with tobacco using patients. J Contemp Dent Pract 2000; 1(4): 37-47.

34. Hanroka T, Ojima M, Hamajima N, Natio M. Patient feedback as a motivating force to quit smoking. J Dent Edu 2007; 35(4): 310-7.

35. Afifah R, Schwarz E. Patient demand for smoking cessation advice in dentist offices after introduction of graphic health warnings in Australia. Aust Dent J 2008; 53(3): 208-16.

36. Franklin DR. Breaking the smoking habit: Behavioral aspects of tobacco cessation. Tex Dent J 2005; 122(6): 558-65.

37. Lavelle C, Birek C, Scott DA. Are nicotine replacement strategies to facilitate smoking cessation safe? J Can Dent Assoc 2003; 69(9): 592-7.

38. Covington LL, Breault LG, O'Brien JJ, Hatfield CH, Vasquez SM, Lutka RW. An innovative tobacco use cessation program for military dental clinics. J Contemp Dent Pract 2005; 6(2): 151-63.

39. Christen AG, Jay SJ, Christen JA. Tobacco cessation and nicotine replacement therapy for dental practice. J Can Dent Assoc 2004; 70(2): 94-8.

40. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation (Review). Cochrane Database Syst Rev 2008; 23(1): CD 000146.

41. Carr AB, Ebbert JO. Interventions for tobacco cessation in the dental setting. Cochrane Database Syst Rev 2006; 25(1): CD 005084.